Stay updated on Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial
Sign up to get notified when there's something new on the Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial page.

Latest updates to the Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.2 was added; the funding-status notice and the earlier Revision: v3.4.1 text were removed.SummaryDifference0.5%

- Check12 days agoChange DetectedA new government funding notice was added clarifying the NIH site status, and the site revision was updated from version 3.4.0 to 3.4.1.SummaryDifference0.5%

- Check19 days agoChange DetectedIntroduces a 'Show glossary' feature and updates footer text and revision metadata (Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0), replacing the previous wording and version (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4).SummaryDifference0.3%

- Check33 days agoChange DetectedSite revision updated from v3.3.3 to v3.3.4 in the footer. This is a minor update and does not affect study details or navigation.SummaryDifference0.1%

- Check55 days agoChange DetectedLocations section has been added, listing Ontario as a location. The page revision updated to v3.3.3, and the previous Ontario Locations entry was removed.SummaryDifference0.3%

- Check77 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. No changes to the study details or page content are visible.SummaryDifference0.1%

Stay in the know with updates to Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial page.